Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Share-based Compensation (2011 - 2026)

Immutep's (IMMP) quarterly Share-based Compensation came in at $1.1 million in Q2 2026, up 51.34% on a YoY basis from $745171.6 in Q2 2025, and up 51.34% quarter-over-quarter from $745171.6 in Q2 2025.

Analysis

Immutep (IMMP) Share-based Compensation (2011 - 2026) Analysis & Trends

Immutep (IMMP) has reported Share-based Compensation for 11 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation rose 51.34% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $4.4 million (up 62.38% YoY), and the FY2026 full-year result was $1.1 million, up 51.34% from the prior year.
  • Share-based Compensation grew to $1.1 million in Q2 2026 per IMMP's latest filing, from $745171.6 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.3 million in Q2 2023 and bottomed at -$560483.5 in Q2 2022.
  • Historically, Share-based Compensation has averaged $766793.5 across 5 years, with a median of $1.1 million in 2026.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation soared 338.68% in 2023, then sank 37.05% in 2025.
  • Over 5 years, Share-based Compensation stood at -$560483.5 in 2022, then jumped by 338.68% to $1.3 million in 2023, then dropped by 11.51% to $1.2 million in 2024, then tumbled by 37.05% to $745171.6 in 2025, then soared by 51.34% to $1.1 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $1.1 million, $745171.6, and $1.2 million for Q2 2026, Q2 2025, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 86.63 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 77.40 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 41.25 Mn
10 Immutep 52.57 Mn 52.57 Mn - 1.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13 Mn
Jun 30, 2025 745,171.57
Jun 30, 2024 1.18 Mn
Jun 30, 2023 1.34 Mn
Jun 30, 2022 -560,483.55
Dec 31, 2021 3.13 Mn
Jun 30, 2021 -477,452.67
Jun 30, 2020 1.13 Mn
Dec 31, 2019 2.35 Mn
Jun 30, 2015 292.00
Jun 30, 2014 57,309.00
Jun 30, 2011 -31,925.89